III. Publication Plan Implementation

Alpert J, Crane E, Smith C, Jones S. Sponsored and non-sponsored reviews: defining best
practice. International Society for Medical Publication Professionals Web site. ISMPP U
Webinar. Talk presented August 19, 2009.

Booth A, Clarke M, Ghersi D, Moher D, Petticrew M, Stewart L. Establishing a minimum
dataset for prospective registration of systematic reviews: an international consultation.
PLoS One. 2011;6(11):e27319.

Chipperfield L, Citrome L, Clark J, et al. Authors’ Submission Toolkit: A practical guide to
getting your research published. CMRO. 2010;26(8):1967-1982.

Citrome, L. What editors look for in a clinically meaningful presentation of trial results in a
manuscript. International Society for Medical Publication Professionals Web site. ISMPP U
Webinar. Talk presented December 14, 2011.

Datto C, Lazarus A. Setting expectations and successful collaboration. International
Society for Medical Publication Professionals Web SIte. ISHPP U Webinar. Talk presented
May 18, 2011.

Dwan K, Altman DG, Cresswell L, Blundell M, Gamble CL, Williamson PR.Comparison of
protocols and registry entries to published reports for randomised controlled trials.
Cochrane Database Syst Rev. 2011;1:MR000031.
http://onlinelibrary.wiley.com/doi/10.1002/14651858.MR000031.pub2/full

Fletcher J, Roberts C. US medical society and regulatory issues regarding abstracts and
posters at scientific congresses. International Society for Medical Publication
Professionals Web site. ISMPP U Webinar. Talk presented May 3, 2006.

Good reprint practices for the distribution of medical journal articles and medical or
scientific reference publications on unapproved new uses of approved drugs and
approved or cleared medical devices. www.fda.gov/RegulatoryInformation/Guidances/
1.UCM125126.htm.

Groves T, Enck R. Author submission toolkit. International Society for Medical Publication
Professionals Web Site. ISMPP U Webinar. Talk presented September 15, 2010.

Graf C, Battisti WP, Bridges D, et al; for the International Society for Medical Publication
Professionals. Good publication practice for communicating company sponsored medical
research: the GPP2 guidelines. BMJ. 2009;339:b4330 doi:10.1136/bmj.b4330.
January 2012 6

Guyatt GH, Haynes RB. Preparing reports for publication and responding to reviewers’
comments. J Clin Epidemiol. 2006;59:900-906.

Lauer, K. The Sunshine Act. International Society for Medical Publication Professionals
Web site. ISMPP U Webinar. Talk presented August 10, 2011.

Norris R, Bowman A, Fagan JM, et al. International Society for Medical Publication
Professionals (ISMPP) position statement: the role of the professional medical writer.
CMRO. 2007;23(8):1837-1840.

O'Kelly M, Julious SA, Pyke S, et al. Making available information from studies
sponsored by the pharmaceutical industry: some current practices. Pharm Stat.
2011;10(1):60-69.

Pharmaceutical Research and Manufacturers of America. Principles on conduct of
CLINICAL TRIALS and communication of CLINICAL TRIAL RESULTS.
http://www.phrma.org/about/principles-guidelines/clinical-trials.

Salt A. Discovering the optimum publication vehicle. International Society for Medical
Publication Professionals Web site. ISMPP U Webinar. Talk presented September 21,
2011.

Schulz KF, Altman DG, Moher D; for the CONSORT Group. CONSORT 2010 statement:
updated guidelines for reporting parallel group randomised trials.
Tse T, Williams RJ, Zarin DA. Reporting “basic results” in ClinicalTrials.gov. CHEST.
2009;136(1):295-303.

Wager E. FDAAA legislation: global implications for clinical trial reporting and publication
planning. November 2008. http://www.keywordpharma.com/prods/wager3.asp.

Welch SJ. Avoiding common problems during online submission of manuscripts. CHEST. 2007;131(5):1591-1594